Mp78-07 Clinical Characteristics Associated With Early Progression or Long-Term Response From the Phase Ii Imvigor210 Study: Atezolizumab in Locally Advanced or Metastatic Urothelial Carcinoma
Journal of Urology - Netherlands
doi 10.1016/j.juro.2018.02.2555
Full Text
Open PDFAbstract
Available in full text
Categories
Date
April 1, 2018
Authors
Publisher
Ovid Technologies (Wolters Kluwer Health)